0815 - 0.1 Opening Remarks - Peter Hillmen
10:15
Chronic Lymphocytic Leukemia
0815 - 0.1 Opening Remarks - Peter Hillmen
Chronic Lymphocytic Leukemia Similar Videos
Similar Videos
-
Module 3: Zanubrutinib for Hematologic Malignancies_Matthew Davids, MD, MMSc_Catherine Coombs, Anthony Mato, MD, MSCE
7:59
-
Module 1: Ibrutinib for Hematologic Malignancies_Matthew Davids, MD, MMSc_Catherine Coombs_MD_Anthony Mato, MD, MSCE
9:28
-
Practical issues in CLL care: oral adherence, MRD testing, and managing treatment-related adverse events_Nicole Lamanna, MD; #BeyondASCO
12:51
